Insulet
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Insulet 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PODD
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals.
CEOAshley A. McEvoy
CEOAshley A. McEvoy
Employees3,900
Employees3,900
HeadquartersActon, Massachusetts
HeadquartersActon, Massachusetts
Founded2000
Founded2000
Employees3,900
Employees3,900
PODD Key Statistics
Market cap21.73B
Market cap21.73B
Price-Earnings ratio90.19
Price-Earnings ratio90.19
Dividend yield—
Dividend yield—
Average volume941.64K
Average volume941.64K
High today—
High today—
Low today—
Low today—
Open price$312.91
Open price$312.91
Volume0.00
Volume0.00
52 Week high$354.88
52 Week high$354.88
52 Week low$230.05
52 Week low$230.05
Stock Snapshot
Insulet(PODD) stock is priced at $310.00, giving the company a market capitalization of 21.73B. It carries a P/E multiple of 90.19.
Insulet(PODD) stock opened on 2025-12-03 at $312.91. The price climbed to — and dipped to —.
Insulet(PODD) shares are trading with a volume of 0, against a daily average of 941.64K.
In the last year, Insulet(PODD) shares hit a 52-week high of $354.88 and a 52-week low of $230.05.
In the last year, Insulet(PODD) shares hit a 52-week high of $354.88 and a 52-week low of $230.05.
PODD News
Nasdaq 5d
Friday Sector Laggards: Healthcare, Consumer ProductsIn afternoon trading on Friday, Healthcare stocks are the worst performing sector, showing a 0.2% loss. Within that group, Insulet Corp (Symbol: PODD) and West...
Analyst ratings
89%
of 28 ratingsBuy
89.3%
Hold
10.7%
Sell
0%
People also own
Based on the portfolios of people who own PODD. This list is generated using Robinhood data, and it’s not a recommendation.